Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
16:19:23 EDT Tue 11 Aug 2026
Enter Symbol
or Name
USA
CA



Q:TLTFF - THERALASE TECHNOLOGIES INC - https://theralase.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TLTFF - Qnot subscribed0.1364-0.0371-21.4675.2901230.1735  0.1735  0.13620.3061  0.101915:57:42Aug 0715 min RT 2¢

Recent Trades - Last 10 of 123
Time ETExPriceChangeVolume
15:57:42Q0.1364-0.03714,500
15:57:26Q0.1364-0.03712,500
15:57:23Q0.1362-0.03733,000
15:57:23Q0.1362-0.0373500
15:57:10Q0.1362-0.03734,500
15:56:52Q0.1362-0.03736,000
15:56:51Q0.1362-0.03738,500
15:56:34Q0.1362-0.03731,000
15:56:27Q0.1362-0.0373500
15:56:27Q0.1362-0.0373500

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-08-07 17:26U:TLTFFNews ReleaseTheralase(R) Grants Stock Options
2026-08-04 07:02U:TLTFFNews ReleaseTheralase(R) Engages Global One Media to Expand Global Investor Awareness
2026-06-30 16:32U:TLTFFNews ReleaseTheralase(R) Receives Receipt for C$100 Million Base Shelf Prospectus
2026-06-03 07:02U:TLTFFNews ReleaseTheralase(R) Lists Warrants on the TSXV
2026-05-29 17:05U:TLTFFNews ReleaseTheralase(R) Releases Q1 2026 Financial Statements
2026-05-04 17:23U:TLTFFNews ReleaseTheralase(R) Releases 2025 Annual Financial Statements and Provides Clinical Study Update
2026-04-13 07:01U:TLTFFNews ReleaseTheralase(R) Reports Complete Response with X-Ray-Activated Rutherrin(R) in Muscle Invasive Bladder Cancer Preclinical Study
2026-04-10 07:01U:TLTFFNews ReleaseTheralase(R) Closes $CAN 2.66 Million Financing
2026-03-17 07:02U:TLTFFNews ReleaseTheralase(R) Discovers Further Mechanism on How Ruvidar(R) Inactivates Herpes Simplex Virus
2026-03-10 07:02U:TLTFFNews ReleaseTheralase(R) Closes $1.1 M Non-Brokered Private Placement
2026-03-09 07:02U:TLTFFNews ReleaseTheralase(R) Demonstrates That X-Ray-Activated Rutherrin(R) Is Significantly More Effective than Radiation Alone in the Destruction of Muscle Invasive Bladder Cancer
2026-03-02 07:02U:TLTFFNews ReleaseLight-Activated Ruvidar and Interferon Demonstrate Enhanced Efficacy
2026-02-20 07:01U:TLTFFNews ReleaseCorrecting and Replacing: Theralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
2026-02-17 07:02U:TLTFFNews ReleaseTheralase Bladder Cancer Clinical Data to be Presented at the 2026 European Association of Urology Congress
2026-02-10 07:02U:TLTFFNews ReleaseTheralase(R) Bladder Cancer Clinical Data to be Presented at the 2026 American Urological Association Annual Meeting
2026-02-04 07:02U:TLTFFNews ReleaseTheralase(R) Provides Update on Bladder Cancer Clinical Study
2026-02-02 07:03U:TLTFFNews ReleaseTheralase(R) Completes Enrollment in Bladder Cancer Clinical Study
2026-01-12 07:02U:TLTFFNews ReleaseFerring Pharmaceuticals and Theralase(R) Technologies Announce Clinical Development Agreement to Investigate Combination Therapy in Bladder Cancer
2025-12-23 16:41U:TLTFFNews ReleaseTheralase(R) Closes $1.3 M Non-Brokered Private Placement
2025-12-12 17:01U:TLTFFNews ReleaseTheralase(R) Commences Non-Brokered Private Placement and Termination of Previously Announced Financing